1/9
06:10 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/7
03:24 pm
olma
Rating for OLMA
Low
Report
Rating for OLMA
1/7
08:20 am
olma
Olema Oncology initiated with a Buy at UBS
Medium
Report
Olema Oncology initiated with a Buy at UBS
1/7
02:01 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Medium
Report
Olema Pharmaceuticals (NASDAQ:OLMA) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
12/12
08:02 am
olma
Rating for OLMA
Low
Report
Rating for OLMA
12/12
08:02 am
olma
Rating for OLMA
Low
Report
Rating for OLMA
12/11
12:52 pm
olma
Rating for OLMA
Low
Report
Rating for OLMA
12/11
12:52 pm
olma
Rating for OLMA
Low
Report
Rating for OLMA
12/11
12:26 pm
olma
Rating for OLMA
Medium
Report
Rating for OLMA
12/11
12:26 pm
olma
Rating for OLMA
Medium
Report
Rating for OLMA
12/11
12:26 pm
olma
Rating for OLMA
Medium
Report
Rating for OLMA
11/21
12:51 pm
olma
Rating for OLMA
Medium
Report
Rating for OLMA
11/21
12:51 pm
olma
Rating for OLMA
Medium
Report
Rating for OLMA
11/21
12:51 pm
olma
Rating for OLMA
Medium
Report
Rating for OLMA
10/20
08:06 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
High
Report
Olema Pharmaceuticals (NASDAQ:OLMA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
10/20
08:06 am
olma
Olema Pharmaceuticals (NASDAQ:OLMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
High
Report
Olema Pharmaceuticals (NASDAQ:OLMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.